جستجوی استاد راهنمای دانشگاهی

• Microbial Ecology
• Marine Microbiology
• Harmful Algal Blooms (HABs)
• +۱۱ مورد دیگر

Kathleen Cusick is an Assistant Professor in the Department of Biological Sciences at the University of Maryland, Baltimore County (UMBC). Her research bridges microbiology and marine ecology, focusing on harmful algal blooms (HABs), microbial genomics, and environmental stress responses in marine bacteria. Education: Postdoc, Chemistry Division, US Naval Research Laboratory (2016) Postdoc, University of Tennessee (2013) PhD in Microbiology, University of Tennessee (2009) MS in Marine Biology, Florida Institute of Technology/Harbor Branch Oceanographic Institute (2000) BS, Dickinson College (1997) Her research integrates molecular biology, genomics, and ecotoxicology to study the ecology and evolution of toxic, bioluminescent dinoflagellates like Pyrodinium bahamense , and metal resistance mechanisms in marine bacteria such as Alteromonas macleodii . She investigates how environmental stressors like copper influence microbial adaptation, biofilm formation, and horizontal gene transfer. Her work spans fields including microbial genetics, environmental microbiology, and molecular ecology. Analysis of her recent publications reveals a strong focus on microbial responses to environmental stress, particularly copper exposure, and the genetic basis of bioluminescence and toxin production in HABs. Her studies employ advanced techniques such as qPCR, transcriptomics, and comparative genomics, often applied to marine systems with ecological and public health implications. Scientific Awards: Early Career Travel Grant, Association for the Sciences of Limnology and Oceanography (2011) Sigma Xi Grant-in-Aid (1998–1999) NASA Graduate Student Researchers Program Fellowship (2005–2008) National Academies Post-doctoral Fellowship (2013–2016) Summer Research Faculty Fellowship, UMBC (2018) Kathleen Cusick has secured significant funding from agencies including NASA, the National Academies, and UMBC. She actively mentors students and collaborates on projects related to genetic system development in Alteromonas , intracellular signaling, and HAB dynamics. Her research has implications for environmental monitoring, antifouling technologies, and understanding marine microbial resilience. She is involved in ongoing research projects including the development of a genetic system for Alteromonas , studies on intracellular signaling, and exploring the link between toxicity and bioluminescence in HABs.

Christopher J. Easleyمشاهده پروفایل

استاد

• Analytical Chemistry
• Biochemistry
• Clinical Lab Sciences
• +۴ مورد دیگر

Christopher J. Easley is the C. Dent Williams Professor of Bioanalytical Chemistry at Auburn University's Department of Chemistry and Biochemistry. He leads the Easley Lab, focusing on developing novel microanalytical techniques for studying endocrine tissue function and biosensing. His roles include ADR Fellow, Graduate Program Officer, and Associate Editor for Analytical Methods . Easley earned his Ph.D. from the University of Virginia (2006) and B.S. from Mississippi State University (2002), with postdoctoral training at Vanderbilt University Medical Center. Affiliations: College of Sciences and Mathematics (COSAM), Royal Society of Chemistry (Associate Editor) Research interests include droplet microfluidics for tissue secretion analysis, cooperative DNA-based biosensors, and electrochemical detection platforms. His lab's work spans analytical chemistry, molecular biology, and device engineering. Key publications (2020–2024) focus on adipose tissue dynamics, electrochemical proximity assays, and µChopper device innovations. Awards include the Dean's Faculty Research Award (2020) and AES Mid-Career Achievement (2019). Current students include Andresa Bezerra (Ph.D. candidate) and Sabita Dangol. Former students have transitioned to roles at institutions like South China Normal University and QPS Holdings. The lab's funding sources include NIH (R01 grants), NSF, and Auburn University's Intramural Grants Program. Lab infrastructure includes specialized microfluidic devices, electrochemical setups, and collaborations with Vanderbilt and UCSF researchers.

Deborah Williamsonمشاهده پروفایل

استاد

• Infectious Diseases
• Genomics
• Microbiology
• +۶ مورد دیگر

Professor Deborah Williamson is Dean of Medicine and Head of the School of Medicine at the University of St Andrews, UK, where she also holds the position of Professor of Medicine within the School of Medicine and the Department of Medical & Biological Sciences. She brings extensive leadership experience from academic and public health institutions across Australia, New Zealand, and the UK, and is a globally recognized clinician-scientist in infectious diseases. Her research focuses on leveraging genomics and innovative technologies to combat infectious diseases such as syphilis, gonorrhea, SARS-CoV-2, and Salmonella . With over 300 journal publications and significant research funding, her work contributes to global public health and the UN Sustainable Development Goals, particularly in health and well-being. The recent publications highlight a consistent focus on molecular diagnostics, pathogen genomics, and public health implementation. Her research spans clinical microbiology, serological assay evaluation, quality assurance in diagnostics, and immune responses to viral infections. The work is collaborative, translational, and globally impactful, especially in low-resource and regional settings. Scientific Awards: L'Oreal-UNESCO Women in Science Fellowship Professor Williamson actively advises research teams and has secured significant funding for her work. She continues to mentor early-career researchers and is deeply involved in advancing medical education at St Andrews. Her leadership integrates clinical service, research innovation, and academic training. She leads a dynamic research group focused on infectious disease genomics and collaborates widely across international networks, particularly in the Indo-Pacific region. Her lab contributes to large-scale surveillance initiatives, including the GenomeTrakr project for Salmonella enterica .

Iva Tchasovnikarovaمشاهده پروفایل

پژوهشگر

• Epigenetics
• Chromatin Regulation
• Genetic Pathways
• +۵ مورد دیگر

Iva Tchasovnikarova is a Researcher in the Department of Biochemistry at the University of Cambridge. She is affiliated with the Gurdon Institute and leads a research group focused on epigenetic pathways and chromatin regulation. Her research explores the fundamental biology of epigenetic mechanisms, including DNA/RNA/histone modifications, their role in transcription and DNA repair, and how dysregulation contributes to developmental disorders and cancer. She employs CRISPR/Cas9 and genetic screens to identify novel chromatin regulators, with a particular emphasis on developing human cell-based models to study their therapeutic potential. Key publications highlight her work on the HUSH complex, Polycomb repression, and MORC2 mutations in neurodevelopmental diseases. Her articles demonstrate interdisciplinary approaches bridging epigenetics, virology, and human disease modeling. Her research has implications for understanding chromatin dynamics in health and disease, and she collaborates with institutions like the Gurdon Institute to advance these studies. Contact: it257@cam.ac.uk

• Genetics of Aging
• Molecular Genetics
• Drosophila Development
• +۳ مورد دیگر

Theodore J. Brummel is an Associate Professor of Biology in the College of Liberal Arts and Sciences at Long Island University. He is actively engaged in academic and research activities within the Department of Biology. Education: B.A., Transylvania University Ph.D., University of California, Irvine His primary research interests include the Genetics of Aging , Molecular Genetics of Drosophila Development , Symbiosis , and Immunity and Aging . His work leverages model organisms such as Drosophila to investigate fundamental biological processes related to lifespan, development, and host-microbe interactions. The published articles reflect a strong focus on interdisciplinary research at the intersection of genetics, microbiology, and aging. Key themes include the role of exogenous bacteria in lifespan modulation, feeding behavior analysis in Drosophila, immune system changes during aging, and molecular tools for wildlife conservation genetics. Scientific Contributions: Co-authored research published in Proceedings of the National Academy of Sciences (PNAS) Contributions to molecular ecology through microsatellite development Research bridging molecular biology and organismal aging Dr. Brummel advises students and contributes to academic leadership as Chair of the Biology Department. Although specific grants and student advisees are not listed, his publication record suggests active mentorship and externally funded research. He is associated with no specialized lab or team name in the provided text.

Diana S-L. Chowمشاهده پروفایل

استاد

• Translational Drug Development
• Oncology
• Pharmacokinetics
• +۳ مورد دیگر

Diana S-L. Chow is a Professor in the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston College of Pharmacy . She also holds the Paula & John J. Lovoi Sr. Endowed Professor in Drug Discovery and Development and serves as Director of the Institute of Drug Education and Research . B.S. in Pharmacy, National Taiwan University, School of Pharmacy M.S. in Natural Product Chemistry, Ohio State University Ph.D. in Pharmaceutics, University of British Columbia Dr. Chow's research spans 40 years of translational drug development with a focus on anti-cancer therapies . She has pioneered formulations resulting in FDA-approved products like Busulfex® , with ongoing work on lung, pancreatic, and prostate cancer treatments. Her recent studies expand to underrepresented minority (URM) populations , pediatrics, and neurologically injured patients, emphasizing pharmacokinetics/pharmacodynamics (PK/PD) optimization. Her publications highlight expertise in analytical method development (e.g., LC-MS/MS assays), nanoparticle-based drug delivery , and neuroprotective agents . Key themes include preclinical-to-clinical translation , metabolite quantification , and bioavailability enhancement . 2023 Meritorious Achievement Award, UH College of Pharmacy 2023 Pharmaceutical Sciences Alumni Agent of Change, University of British Columbia 2016 Fellow, National Academy of Inventors 2009 Inventor of the Year, HIPLA Dr. Chow mentors extensively, with recognition as Outstanding Graduate Mentor (2022, 2021), and contributes to graduate education and research infrastructure through her directorship.

• Biophysics
• Nanoscience
• Fluorescence Microscopy
• +۳ مورد دیگر

G. Ulrich Nienhaus is a Professor at the Institute of Applied Physics , Karlsruhe Institute of Technology (KIT) , and leads a research group focused on Biophysics and Nanoscopy . His work integrates physics, biology, chemistry, and computational methods to develop advanced light microscopy techniques with high spatial and temporal resolution. Key research areas include fluorescent protein engineering , single-molecule spectroscopy , super-resolution microscopy , and nanoparticle-biomolecule interactions . His group investigates molecular processes in living cells , protein folding , ligand dynamics , and quantitative imaging for biomedical and material science applications. Scientific Contributions span decades, with recent work highlighting innovative STED microscopy methods, DNA origami-based distance rulers , and fluorescent nanocluster applications . Publications emphasize biomolecular dynamics , nanoparticle corona formation , and live-cell imaging tools .

• Cancer Drug Development
• Translational Research
• Pre-clinical Studies
• +۵ مورد دیگر

Rena S. Lapidus, PhD is an Associate Professor in the Department of Medicine at the University of Maryland School of Medicine. She serves as the Director of the Translational Laboratory Shared Service (TLSS) at the University of Maryland Greenebaum Comprehensive Cancer Center (UMGCCC), where she also holds the positions of Project Coordinator of the Translational Working Group and Assistant Director of the UMGCCC Shared Services. With over 23 years of experience spanning both industry and academia, Dr. Lapidus brings extensive expertise in cancer drug development and translational research. Dr. Lapidus earned her Bachelor of Arts in Chemistry from Boston University, followed by a PhD in Pharmacology from the University of Maryland School of Medicine. She completed her postdoctoral training at The Johns Hopkins Oncology Center. Her career includes 12 years in the pharmaceutical industry working on small molecule drug development, followed by 11 years leading the TLSS at UMGCCC. Dr. Lapidus's research focuses on translating novel drugs from bench to bedside through comprehensive preclinical testing. Her laboratory specializes in cancer drug development , particularly for acute myeloid leukemia (AML), with expertise in translational research , pre-clinical studies , and in vivo cancer models . The TLSS under her direction conducts both in vitro studies (proliferation and cell death assays, IC50 generation, apoptotic assays, Western analysis) and in vivo studies (maximum tolerated dose studies, pharmacokinetic studies, cancer efficacy and pharmacodynamic studies). The laboratory has developed numerous novel flank, orthotopic and primary xenograft models to test novel compounds in cancer and possesses an umbrella Animal Use protocol approved for oncology studies. Analysis of Dr. Lapidus's recent publications (2023-2025) reveals a strong focus on innovative therapeutic approaches for acute myeloid leukemia, particularly exploring combinations of pegcrisantaspase with venetoclax and other agents to overcome drug resistance. Her work also extends to pancreatic cancer, head and neck squamous cell carcinoma, and breast cancer, with particular emphasis on metabolic targeting, epigenetic therapies, and biomarker development for treatment response prediction. A notable trend is her investigation of amino acid metabolism (particularly glutamine) as a therapeutic target in hematologic malignancies. Dr. Lapidus has extensive experience mentoring researchers and collaborating on translational projects. Her laboratory serves as a critical resource for UMGCCC investigators seeking preclinical data to support grant applications and clinical trial development. The TLSS provides essential services including in vitro and in vivo testing of novel compounds, pharmacokinetic studies, and development of specialized cancer models. The Translational Laboratory Shared Service under Dr. Lapidus's direction is equipped with the necessary tools to generate in vivo oncology data for preclinical investigators. The laboratory has particular expertise in developing and utilizing various xenograft models to test novel cancer therapeutics. Dr. Lapidus's unique background bridging industry drug development and academic research enables her to effectively translate scientific discoveries into clinically relevant applications.

Elizabete Carmo-Silvaمشاهده پروفایل

استاد

• Photosynthesis
• Rubisco
• Crop Physiology
• +۱۱ مورد دیگر

Professor Elizabete Carmo-Silva is a leading expert in crop physiology at Lancaster University's Lancaster Environment Centre. She specializes in the regulation of carbon assimilation by Rubisco in crop plants, particularly wheat and cowpea, with research focused on improving photosynthetic efficiency to enhance agricultural sustainability and climate resilience. Her research interests center on photosynthesis, Rubisco regulation, and sustainable agriculture. She leads a research team investigating how to optimize photosynthetic processes to improve crop yields under environmental stress conditions including heat, drought, and fluctuating light. Her work bridges fundamental plant biochemistry with practical crop improvement strategies to address food security challenges. Professor Carmo-Silva's publication record demonstrates consistent contributions to understanding Rubisco regulation, photosynthetic efficiency, and crop adaptation. Her recent work has focused on Rubisco activase isoforms, thermotolerance mechanisms, and developing methodologies for measuring photosynthetic parameters. Her research has significant implications for breeding crops with improved resource use efficiency and climate resilience. Fellow of the Royal Society of Biology (2022) LEAF accreditation for Rubisco lab Handling Editor for Journal of Experimental Botany (2021-present) She actively supervises four PhD students and leads a multidisciplinary research team working on major projects including RIPE, CAPITALISE, PhotoBoost, and Delivering Sustainable Wheat. Professor Carmo-Silva also contributes to teaching through the Research Design and Delivery course, Biology and Ecology & Conservation programmes, and serves as Director of LEC Postgraduate Research Programmes and Lancaster academic lead for UKRI NorthWestBio Doctoral Programme.

John A. Stanfordمشاهده پروفایل

استاد

• Neuroscience
• Motor Disorders
• Neurodegenerative Diseases
• +۴ مورد دیگر

John A. Stanford is a Professor in the Department of Cell Biology and Physiology at the University of Kansas School of Medicine, serving as Associate Dean for Research and Graduate Education since 2004. He also directs the Kansas IDeA Network for Biomedical Research Excellence (K-INBRE), a multi-institutional initiative enhancing undergraduate research training. His academic credentials include: BA in Psychology, University of Mississippi MA in Psychology, University of Kansas PhD in Psychology, University of Kansas Post Doctoral Fellowship in Neurobiology of Aging, University of Colorado & University of Kentucky Dr. Stanford employs systems neuroscience and rodent models to investigate motor dysfunction in Parkinson's disease, ALS, neonatal jaundice, and aging. His lab pioneered bulbar deficit studies in ALS rodent models and explores isometric strength training's impact on disease progression. Current projects examine neonatal hyperbilirubinemia's neurological effects and obesity-neurodegeneration links through metabolic challenge studies. Analysis of his 15 most recent publications (2021-2025) reveals dominant focus on exercise interventions for neurodegenerative diseases, particularly resistance training in ALS and aging models. Key themes include mitochondrial function in brain aging, intrinsic aerobic capacity as a protective factor, and metabolic challenges exacerbating neurodegeneration. His work bridges basic neuroscience with translational applications through innovative rodent exercise paradigms. Award Recognition: Fellow, American Society for Neural Therapy and Repair As K-INBRE Program Director, Dr. Stanford manages federal grants supporting undergraduate research across 10 institutions. His NIH-funded research examines motor deficits and neuroprotective strategies, with mentorship extending to graduate students and postdocs. His laboratory maintains expertise in operant behavioral methods and neuromuscular physiology. Current initiatives include developing resistance exercise protocols for preclinical studies and investigating gut-brain axis interactions in obesity-related neurodegeneration, with ongoing work translating rodent findings to human clinical applications.

Elisha Kriegمشاهده پروفایل

استادیار

• DNA Nanotechnology
• Programmable Materials
• Biomaterials
• +۳ مورد دیگر

Dr. Elisha Krieg serves as Group Leader at the Leibniz Institute for Polymer Research Dresden and TUD Young Investigator at Dresden University of Technology, Germany. Her research pioneers programmable biomaterials using DNA nanotechnology for advanced biomedical applications, bridging synthetic polymer science with biological complexity. Her academic foundation includes: Ph.D. in Chemistry, Weizmann Institute of Science, Israel (2013) M.Sc. in Chemistry, Weizmann Institute of Science, Israel (2009) Vordiplom in Chemistry, University of Cologne, Germany (2006) Krieg's work centers on developing DNA-based nanomaterials that translate nanoscale programmability to macroscopic functional materials. Her group designs synthetic polymers functionalized with DNA modules to create reconfigurable platforms for diagnostics, tissue engineering, and nucleic acid purification. This approach leverages DNA's molecular precision to overcome limitations of conventional synthetic polymers, enabling dynamic biomaterials that respond to biological cues. Recent publications reveal a clear trajectory toward clinical translation, with 12 of 15 recent papers focusing on DNA-encoded hydrogels for cell culture matrices and nucleic acid diagnostics. The research spans fundamental supramolecular chemistry to applied biomedical engineering, emphasizing scalability and point-of-care compatibility. Key recognition includes: HFSP Postdoctoral Fellowship during Harvard tenure Krieg actively recruits MSc/PhD students through DIGS-BB and secures competitive funding including the TUD Young Investigator program. Her mentorship emphasizes interdisciplinary training in polymer chemistry, molecular biology, and nanomaterial characterization. Current grants support three core application areas: DNA/RNA purification for sequencing diagnostics, dynamic 3D cell culture matrices, and pathogen detection systems. The Krieg Group operates within the Max Bergmann Center of Biomaterials, utilizing advanced facilities for DNA nanotechnology, polymer synthesis, and nanomaterial characterization including cryo-EM and rheology.

Julia L. Finkelsteinمشاهده پروفایل

دانشیار

• Epidemiology and Nutrition
• One-carbon metabolism
• Maternal and child health
• +۳ مورد دیگر

Julia L. Finkelstein, MS, MPH, ScD, is Associate Professor of Epidemiology and Nutrition in the Division of Nutritional Sciences at Cornell University’s College of Human Ecology and concurrently Associate Professor of Epidemiology in the Division of Epidemiology, Department of Population Health Sciences at Weill Cornell Medical College. She is the Follett Sesquicentennial Faculty Fellow , Director of the Maternal and Child Nutrition Program , and co-Director of the Joan Klein Jacobs Center for Precision Nutrition and Health , the Cochrane Center , and the WHO Collaborating Centre at Cornell. She also holds an adjunct Associate Professor appointment at St. John’s Research Institute, Bengaluru, India . Education Bachelor of Science – McGill University, Montréal, Canada Master of Public Health – Brown University, USA Master of Science – Harvard University (Epidemiology and Nutrition) Doctor of Science – Harvard University (Epidemiology and Nutrition) Research Focus Dr. Finkelstein is an epidemiologist whose laboratory centers on one-carbon metabolism and its role in women’s health across the lifespan—from preconception through pregnancy and postpartum. She designs and conducts large-scale randomized clinical trials, cohort studies, and surveillance programs in resource-limited settings in India, Sub-Saharan Africa, Latin America, and the United States . Her work integrates precision nutrition, mobile point-of-care diagnostics, and AI-driven analytics to improve maternal, neonatal, and child health outcomes. Scientific Awards & Honors NIH Technology Accelerator Challenge Prize – Innovative Global Health Diagnostics SUNY Chancellor Award for Scholarship & Creative Activities International Life Sciences Institute (ILSI) Award – Leadership in Nutrition Chair, Federation of American Societies for Experimental Biology (FASEB) One-Carbon Metabolism Research Interest Group (recently elected) Grants & Leadership Roles Dr. Finkelstein is Program Director of an NIH-funded training program on maternal and child nutrition and leads the Clinical Core of the NIH-funded PORTENT Center (Point-of-Care Diagnostics for Nutrition, Infection, and Cancer) within the NIH POCTRN network. She is a Global Public Voices Fellow (2021–22) through Cornell’s Einaudi Center, advocating for social and health equity in vulnerable populations. Laboratory & Teams The Finkelstein Laboratory at Cornell focuses on mechanistic and translational research in one-carbon metabolism, leveraging state-of-the-art biomarker assays, body-composition analyses, and microbiome profiling to develop and test precision nutrition interventions for women and children globally.

• Analytical Chemistry
• Mass Spectrometry
• Biomaterials
• +۱۲ مورد دیگر

Lisa Elviri is an Associate Professor in Analytical Chemistry at the Department of Pharmacy, University of Parma, Faculty of Sciences. She holds a PhD in Chemical Sciences (Analytical Chemistry) from the University of Parma and has been a tenured researcher since 2004. Education: PhD in Chemical Sciences (Analytical Chemistry, University of Parma); Laurea in Chemistry (University of Parma). Her research spans analytical chemistry , mass spectrometry , biomaterials , 3D printing , and clinical diagnostics . She focuses on developing LC-MS and immunoenzymatic methods, validating techniques for pharmaceutical analysis, and designing chitosan-based scaffolds for tissue regeneration. Recent publications highlight work on Alzheimer’s disease (PCSK9 inhibition, APOE4 genotype studies), 3D-printed medical devices , and biorefinery quality monitoring using spectroscopy. Her teaching includes Analytical Chemistry for 5-year Master’s programs in Pharmacy and Pharmaceutical Chemistry. She has authored 75 international publications, 140 conference communications, and holds an H-index of 26 (Google Scholar). Her office is located at the Science and Technology Campus, Parma.

• Neurodegeneration
• Parkinson's Disease
• Mitochondrial Biology
• +۵ مورد دیگر

Tony Schapira is Professor of Neurological Science at University College London (UCL) and Head of the Department of Clinical Neurosciences at UCL Institute of Neurology. He serves as a Consultant Neurologist at the National Hospital for Neurology and Neurosurgery and Royal Free Hospital, and holds additional leadership positions as Vice Dean of UCL Medical School and Director of the Royal Free Campus. His academic appointments include Visiting Professorships at Harvard (2009) and Yale (2010). Education includes: Bachelor of Science (Honours) from King's College London (1976) Bachelor of Medicine/Bachelor of Surgery from Charing Cross and Westminster Medical School (1979) Member of the Royal College of Physicians (1982) His primary research investigates neurodegeneration mechanisms in Parkinson's disease (PD), with emphasis on mitochondrial dysfunction, alpha-synuclein pathology, and GBA1 mutation pathways. His work spans molecular pathogenesis, drug development for disease modification, and clinical phenotyping of at-risk populations. Current projects focus on identifying prodromal biomarkers and developing neuroprotective therapies through international clinical trials. Schapira's recent publications (2024-2025) demonstrate concentrated research in Parkinson's disease mechanisms, mitochondrial biology, genetic risk factors (particularly GBA1 variants), and novel therapeutic approaches. Article themes consistently explore protein aggregation pathways, lysosomal function, metabolic interactions, and clinical trial methodologies. Awards and honors include: Fellow of the Academy of Medical Sciences (1999) Undergraduate Scholarship at Westminster Medical School He has supervised 11 PhD students and one MD candidate, and currently mentors post-graduate and post-doctoral researchers. His department received UCL's 'Excellence in Medical Education' award (2007-2008). Major grants include co-principal investigator roles on: MRC-Wellcome Strategic Award in Neurodegeneration (£6 million) Wolfson Award (£20 million) He directs a research department comprising 3 Readers, a Senior Lecturer, technicians, and academic staff, with facilities for biochemistry, molecular biology, tissue culture, and advanced imaging. The team investigates neurodegenerative disorders including Parkinson's, Huntington's, and Friedreich's ataxia.

Mark Farmanمشاهده پروفایل

استاد

• Fungal Pathogenesis
• Genomics
• Molecular Biology
• +۳ مورد دیگر

Mark Farman is a Professor at the University of Kentucky, affiliated with the Martin-Gatton College of Agriculture, Food and Environment and the Department of Plant Pathology. He serves as Director of the Advanced Genetic Technologies Center and leads the Farman Lab. Research Focus: The Farman Lab investigates fungal pathogenesis mechanisms in Magnaporthe oryzae , emphasizing fungal genome evolution, telomere roles in pathogenic variation, and high-throughput protein localization during host infection. Teaching: Courses include PPA 600 (Critical Methods in Plant-Microbe Interactions), PPA 500 (Physiology of Plant Health and Disease) as guest lecturer, and PPA 784 (Special Problems in Plant Pathology). Educational Background: PhD in Molecular Biology (1990) and BS in Biology (1983) from the University of East Anglia, UK. Basil O'Connor Starter Scholar Award (1999)